{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:37:49Z","timestamp":1792575469298,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jaccao.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T19:20:11Z","timestamp":1776799211000},"page":"181-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["PD-L1 in ICI Myocarditis"],"prefix":"10.1016","volume":"8","author":[{"given":"Adrian C.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid J.","family":"Moslehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jaccao.2026.03.003_bib1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/eurheartj\/ehaf315","article-title":"Immune checkpoint inhibitor-associated myocarditis: a novel risk score","volume":"47","author":"Power","year":"2026","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jaccao.2026.03.003_bib2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaccao.2022.11.005","article-title":"Immune checkpoint inhibitor myocarditis treatment strategies and future directions","volume":"4","author":"Moslehi","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"2","key":"10.1016\/j.jaccao.2026.03.003_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaccao.2026.03.006","article-title":"Myocardial expression of PD-L1 as a marker of poor prognosis in immune checkpoint inhibitor\u2013associated myocarditis","volume":"8","author":"Imaoka","year":"2026","journal-title":"JACC CardioOncol"},{"issue":"8","key":"10.1016\/j.jaccao.2026.03.003_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41568-024-00715-5","article-title":"Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart","volume":"24","author":"Munir","year":"2024","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.jaccao.2026.03.003_bib5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.jaccao.2026.03.003_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.122.062551","article-title":"Expansion of pathogenic cardiac macrophages in immune checkpoint inhibitor myocarditis","volume":"149","author":"Ma","year":"2024","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.jaccao.2026.03.003_bib7","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1161\/CIRCULATIONAHA.107.709360","article-title":"Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell-mediated injury in the heart","volume":"116","author":"Grabie","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jaccao.2026.03.003_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008563","article-title":"PD-L1 (programmed death ligand 1) as a marker of acute cellular rejection after heart transplantation","volume":"14","author":"Choudhary","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"7","key":"10.1016\/j.jaccao.2026.03.003_bib9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1158\/1078-0432.CCR-10-0250","article-title":"Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma","volume":"17","author":"Frigola","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jaccao.2026.03.003_bib10","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/s41467-018-07131-y","article-title":"Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer","volume":"9","author":"Niemeijer","year":"2018","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.jaccao.2026.03.003_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCULATIONAHA.124.065473","article-title":"Cardio-oncology: a new clinical frontier and novel platform for cardiovascular investigation","volume":"150","author":"Moslehi","year":"2024","journal-title":"Circulation"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087326000608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087326000608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:31:39Z","timestamp":1786404699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087326000608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666087326000608"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.03.003","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-L1 in ICI Myocarditis","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.03.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}